2 unknown. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Unknown 2 |
| Phase 2 | 2 | Unknown 2 |
Follow Dual-target CAR-T Cells: new trials by email Literature Review of Dual-target CAR-T Cells trials Research Report on Dual-target CAR-T Cells
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dual Target CAR-T Cells in B-cell Lymphoma dual target CAR-T cell therapy - Lymphoma, B-Cell, Relapse/Recurrence | Phase 1 / Phase 2 | Unknown | YuLi | 20 | 2020-10-20 | 2021-01-26 |
| Dual Target CAR-T Cells in B-cell Acute Lymphoblastic Leukemia Dual target CAR-T cell therapy - Dual-target CAR-T Cells, B ALL | Phase 1 / Phase 2 | Unknown | Shenzhen University General Hospital | 20 | 2020-10-20 | 2021-01-26 |
Recurrence (2) · Burkitt Lymphoma (1) · Lymphoma (1) · Lymphoma, B-Cell (1)
Disease Attributes (2) · Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Lymphatic Diseases (2) · Lymphoma, Non-Hodgkin (2) · Lymphoproliferative Disorders (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · DNA Virus Infections (1) · Epstein-Barr Virus Infections (1) · Herpesviridae Infections (1) · Infections (1)
Shenzhen University General Hospital (1) · YuLi (1)
China (2)
Li Yu, Dr (2)